Attali Emmanuel, Kern Guy, Fouks Yuval, Reicher Lee, Many Ariel, Levin Ishai, Yogev Yariv, Cohen Aviad
Lis Hospital for Women, Sourasky Medical Center, Tel Aviv, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
J Matern Fetal Neonatal Med. 2022 Dec;35(26):10530-10534. doi: 10.1080/14767058.2022.2134768. Epub 2022 Oct 16.
We aimed to assess the efficacy of three different labor induction methods for non-viable third-trimester fetuses.
This retrospective cohort study included women who had an intra-uterine fetal death or termination of pregnancy at or after 28 weeks of gestation and underwent labor induction by either transcervical foley catheter and concomitant oxytocin infusion or regular doses of vaginal Prostin or Propess.The primary outcome was induction to the delivery interval. Secondary outcomes included the rate of women who delivered within 24 h, time spent in the delivery room, failed induction, adverse outcomes and reported occurrence of moderate to severe pain.
Between January 2017 to June 2020, 107 women met the inclusion criteria. 25 women underwent induction of labor using transcervical foley catheter, 44 using Propess and 58 by Prostin. The three groups were found to be demographically similar. The rate of women who delivered within 24 h was higher in the transcervical foley catheter group compared to the Propess and Prostin groups (72% vs 25% vs 29.3%, < .001 respectively). Time to delivery was shorter among the transcervical foley catheter group compared to the Propess and Prostin groups (16.97 h vs 39.4 vs 39.3, < .001 respectively). When comparing the Foley catheter group to both Propess and Prostin, moderate to severe pain was significantly more commonly reported in the prostaglandins groups (36.0% vs 50.0% vs 65.62%, = .04). No difference was found in adverse outcomes, defined as intrapartum fever, post-partum hemorrhage and retained placenta.
Cervical foley catheter with concomitant oxytocin infusion is the most effective method for induction of labor in third trimester non-viable in fetus compared to PGE2.
我们旨在评估三种不同引产方法对孕晚期不可存活胎儿的引产效果。
这项回顾性队列研究纳入了妊娠28周及以后发生宫内死胎或终止妊娠并接受引产的妇女,引产方法为经宫颈放置福乐导尿管并同时输注缩宫素,或使用常规剂量的阴道用普贝生或地诺前列酮栓。主要结局是引产至分娩的间隔时间。次要结局包括24小时内分娩的妇女比例、在产房的停留时间、引产失败、不良结局以及报告的中度至重度疼痛发生率。
2017年1月至2020年6月期间,107名妇女符合纳入标准。25名妇女采用经宫颈福乐导尿管引产,44名采用地诺前列酮栓引产,58名采用地诺前列酮引产。发现三组在人口统计学上相似。经宫颈福乐导尿管组24小时内分娩的妇女比例高于地诺前列酮栓组和地诺前列酮组(分别为72%、25%和29.3%,P均<0.001)。经宫颈福乐导尿管组的分娩时间短于地诺前列酮栓组和地诺前列酮组(分别为16.97小时、39.4小时和39.3小时,P均<0.001)。将福乐导尿管组与地诺前列酮栓组和地诺前列酮组进行比较时,前列腺素类药物组报告的中度至重度疼痛明显更常见(分别为36.0%、50.0%和65.62%,P = 0.04)。在定义为产时发热、产后出血和胎盘残留的不良结局方面未发现差异。
与前列腺素E2相比,经宫颈福乐导尿管并同时输注缩宫素是孕晚期不可存活胎儿引产的最有效方法。